Authorization

DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group

DGAP-Ad-hoc: Dermapharm Holding SE / Key word(s): Takeover


Dermapharm Holding SE: binding offer to acquire Arkopharma Group


30-Jul-2022 / 20:22 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.



Disclosure of insider information pursuant to Section 17 (1) 1 of Regulation (EU)

No. 596/2014 on market abuse, as amended

(Market Abuse Regulation MAR)



Dermapharm Holding SE: binding offer to acquire Arkopharma Group

GrA 1/4 nwald, July 30, 2022 Today, Dermapharm AG, wholly owned subsidiary of Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8), offered to acquire 100% of the shares in Apharma TopCo SAS, headquartered in Carros, France, from private equity firm Montagu and minority shareholders of the target, for a purchase price approximating EUR 450 million.

Apharma TopCo SAS is the holding company of the Arkopharma Group, a provider of herbal OTC products and dietary supplements in France and other European countries. In the financial year 2021, Arkopharma Group achieved sales of approximately EUR 191 million. For the current financial year 2022, it forecasts sales of slightly over EUR 200 million.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
293031